Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Please note that all translations are automatically generated. Click here for the English version.
DOI :
10.3791/58140-v
October 3rd, 2018
Chapters
0:04
Title
0:39
Recipient Mouse Preparation and Bone Marrow Nucleated Cell (BMNC) Harvest
2:25
BMNC Fluorescence-activated Cell Sorting (FACS) and Hematopoietic Stem Cell Transplantation (HSCT)
4:52
Results: Representative HSCT Analyses
6:08
Conclusion
我々 は遺伝子組み換えの造血細胞の悪性の可能性を評価するために造血幹細胞移植 (造血幹細胞移植) の使用について説明します。造血幹細胞移植、マウス骨髄異形成症候群 (MDS) や白血病の新規治療法を評価するための大規模コホートの生成し同様、生体内で様々 な悪性造血細胞の評価に役立ちます。
Tags
-- Views
Related Videos
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit
Librarians
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
ABOUT JoVE
Leadership
Copyright © 2024 MyJoVE Corporation. All rights reserved